Sevoflurane and thymoquinone can reduce IL-6 and TNF-α by inhibiting the NF-κB and MAPK pathways, partially inhibiting pulmonary vascular remodeling and right ventricular hypertrophy in PH rats (51, 52). This evidence concerns the gene IL6 and Right ventricular hypertrophy.